APT Medical Inc (688617) - Total Liabilities
Based on the latest financial reports, APT Medical Inc (688617) has total liabilities worth CN¥423.50 Million CNY (≈ $61.97 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 688617 cash flow conversion to assess how effectively this company generates cash.
APT Medical Inc - Total Liabilities Trend (2017–2024)
This chart illustrates how APT Medical Inc's total liabilities have evolved over time, based on quarterly financial data. Check 688617 financial resilience to evaluate the company's liquid asset resilience ratio.
APT Medical Inc Competitors by Total Liabilities
The table below lists competitors of APT Medical Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
GS Holdings
KO:078930
|
Korea | ₩16.87 Trillion |
|
China International Marine Containers (Group) Co. Ltd
F:OCM
|
Germany | €107.04 Billion |
|
BRF S.A
F:P5Y
|
Germany | €46.19 Billion |
|
Axos Financial Inc
NYSE:AX
|
USA | $24.64 Billion |
|
Bancolombia S.A
F:BXK
|
Germany | €322.44 Trillion |
|
Farsoon Technology Co. Ltd. A
SHG:688433
|
China | CN¥543.46 Million |
|
Celcuity LLC
NASDAQ:CELC
|
USA | $359.04 Million |
|
Choice Hotels International Inc
NYSE:CHH
|
USA | $2.74 Billion |
Liability Composition Analysis (2017–2024)
This chart breaks down APT Medical Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see APT Medical Inc market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.38 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how APT Medical Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for APT Medical Inc (2017–2024)
The table below shows the annual total liabilities of APT Medical Inc from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥425.85 Million ≈ $62.32 Million |
-30.30% |
| 2023-12-31 | CN¥610.98 Million ≈ $89.41 Million |
+40.48% |
| 2022-12-31 | CN¥434.91 Million ≈ $63.64 Million |
+95.89% |
| 2021-12-31 | CN¥222.02 Million ≈ $32.49 Million |
+60.16% |
| 2020-12-31 | CN¥138.62 Million ≈ $20.29 Million |
-35.56% |
| 2019-12-31 | CN¥215.13 Million ≈ $31.48 Million |
+290.28% |
| 2018-12-31 | CN¥55.12 Million ≈ $8.07 Million |
+43.89% |
| 2017-12-31 | CN¥38.31 Million ≈ $5.61 Million |
-- |
About APT Medical Inc
APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. The company offers electrophysiology products, such as mapping, ablation, and navigated catheter, as well as steerable, and transseptal needle and sheet; and interventional cardiology and peripheral products, including access, diagnostic, therapeutic, and acces… Read more